HEMANGIOL

This brand name is authorized in Austria, Canada, Croatia, Estonia, Finland, France, Ireland, Israel, Japan, Lithuania, Netherlands, Poland, Romania, Spain, Turkey.

Active ingredients

The drug HEMANGIOL contains one active pharmaceutical ingredient (API):

1	Propranolol UNII F8A3652H1V - PROPRANOLOL HYDROCHLORIDE
	Propranolol is a competitive antagonist at both beta, and beta2-adrenoceptor, but has membrane stabilising activity at concentrations exceeding 1-3mg/litre, though such concentrations are rarely achieved during oral therapy. Competitive beta-blockade has been demonstrated in man by a parallel shift to the right in the dose-heart rate response curve to beta-agonists such as isoprenaline.
	Read more about Propranolol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
HEMANGIOL Oral solution	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C07AA05	Propranolol	C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AA Beta blocking agents, non-selective
Discover more medicines within C07AA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02457857
EE	Ravimiamet	1645826
ES	Centro de información online de medicamentos de la AEMPS	114919001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	576993
FR	Base de données publique des médicaments	63558075
IL	מִשְׂרַד הַבְּרִיאוּת	8105
JP	医薬品医療機器総合機構	2900003Q1029
LT	Valstybinė vaistų kontrolės tarnyba	1073203
NL	Z-Index G-Standaard, PRK	118095
PL	Rejestru Produktów Leczniczych	100323088
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W69409001
TR	İlaç ve Tıbbi Cihaz Kurumu	8681349103038